These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31526207)

  • 41. Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression.
    George D; Gálvez V; Martin D; Kumar D; Leyden J; Hadzi-Pavlovic D; Harper S; Brodaty H; Glue P; Taylor R; Mitchell PB; Loo CK
    Am J Geriatr Psychiatry; 2017 Nov; 25(11):1199-1209. PubMed ID: 28739263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial.
    Carspecken CW; Borisovskaya A; Lan ST; Heller K; Buchholz J; Ruskin D; Rozet I
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):305-313. PubMed ID: 29847468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketamine and midazolam is an inappropriate preinduction combination in uncooperative children undergoing brief ambulatory procedures.
    Verghese ST; Hannallah RS; Patel RI; Patel KM
    Paediatr Anaesth; 2003 Mar; 13(3):228-32. PubMed ID: 12641685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot randomized controlled trial of ketamine in Borderline Personality Disorder.
    Fineberg SK; Choi EY; Shapiro-Thompson R; Dhaliwal K; Neustadter E; Sakheim M; Null K; Trujillo-Diaz D; Rondeau J; Pittaro GF; Peters JR; Corlett PR; Krystal JH
    Neuropsychopharmacology; 2023 Jun; 48(7):991-999. PubMed ID: 36804489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.
    Rakhman E; Shmain D; White I; Ekstein MP; Kollender Y; Chazan S; Dadia S; Bickels J; Amar E; Weinbroum AA
    Clin Ther; 2011 Jul; 33(7):863-73. PubMed ID: 21722959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
    Sigtermans M; Dahan A; Mooren R; Bauer M; Kest B; Sarton E; Olofsen E
    Anesthesiology; 2009 Oct; 111(4):892-903. PubMed ID: 19741495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.
    Nimatoudis I; Zissis NP; Kogeorgos J; Theodoropoulou S; Vidalis A; Kaprinis G
    Int Clin Psychopharmacol; 2004 Nov; 19(6):331-6. PubMed ID: 15486518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging study.
    Sramek JJ; Fresquet A; Marion-Landais G; Hourani J; Jhee SS; Martinez L; Jensen CM; Bolles K; Carrington AT; Cutler NR
    J Clin Psychopharmacol; 1996 Dec; 16(6):454-8. PubMed ID: 8959472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.
    Feltner DE; Liu-Dumaw M; Schweizer E; Bielski R
    Int Clin Psychopharmacol; 2011 Jul; 26(4):213-20. PubMed ID: 21368587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of psychotomimetic side effects of Ketalar (ketamine) by Rohypnol (flunitrazepam). A randomized, double-blind trial.
    Freuchen I; Ostergaard J; Kühl JB; Mikkelsen BO
    Acta Anaesthesiol Scand; 1976; 20(2):97-103. PubMed ID: 7095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low- versus high-dose combination of midazolam-ketamine for oral premedication in children for ophthalmologic surgeries.
    Darlong V; Shende D; Singh M; Garg R; Pandey R; Punj J
    Singapore Med J; 2011 Jul; 52(7):512-6. PubMed ID: 21808963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.
    Keefe JR; Mao JJ; Soeller I; Li QS; Amsterdam JD
    Phytomedicine; 2016 Dec; 23(14):1699-1705. PubMed ID: 27912871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Midazolam with ketamine: who benefits?
    Kennedy RM; McAllister JD
    Ann Emerg Med; 2000 Mar; 35(3):297-9. PubMed ID: 10692201
    [No Abstract]   [Full Text] [Related]  

  • 55. Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.
    Gommoll C; Forero G; Mathews M; Nunez R; Tang X; Durgam S; Sambunaris A
    Int Clin Psychopharmacol; 2015 Nov; 30(6):297-306. PubMed ID: 26291335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
    Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial.
    Taylor JH; Landeros-Weisenberger A; Coughlin C; Mulqueen J; Johnson JA; Gabriel D; Reed MO; Jakubovski E; Bloch MH
    Neuropsychopharmacology; 2018 Jan; 43(2):325-333. PubMed ID: 28849779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.